Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

A study led by TUM researchers finds that cystic fibrosis alters immune cells early in life, likely before birth. These ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

Cystic fibrosis is caused by hereditary genetic mutations that impair or halt the production of the CFTR protein. The respiratory tract is most severely affected. There, the mucus becomes so ...

A new EMA approval has expanded the use of Vertex Pharma’s cystic fibrosis therapy Symkevi ... other so-called “minimal function” mutations in CFTR. The new EU approval comes after the ...